Reuters logo
BRIEF-Bone Therapeutics and Asahi Kasei sign exclusive license agreement for Preob in Japan
September 22, 2017 / 5:13 AM / 3 months ago

BRIEF-Bone Therapeutics and Asahi Kasei sign exclusive license agreement for Preob in Japan

Sept 22 (Reuters) - BONE THERAPEUTICS:

* REG-BONE THERAPEUTICS SA AND ASAHI KASEI SIGN EXCLUSIVE LICENSE AGREEMENT FOR PREOB® IN JAPAN

* REG-BONE THERAPEUTICS SA AND ASAHI KASEI SIGN EXCLUSIVE LICENSE AGREEMENT FOR PREOB® IN JAPAN

* ‍ASAHI KASEI WILL OBTAIN EXCLUSIVE RIGHTS TO DEVELOP, REGISTER AND COMMERCIALISE PREOB FOR TREATMENT OF OSTEONECROSIS OF HIP IN JAPAN.​

* TO RECEIVE UPFRONT PAYMENT OF EUR 1.7 MILLION FROM ASAHI KASEI

* ALSO GRANTED ASAHI KASEI OPTION TO NEGOTIATE AN EXCLUSIVE LICENSE FOR DEVELOPMENT AND COMMERCIALIZATION OF PREOB IN KOREA, CHINA AND TAIWAN.​

* TO RECEIVE UP TO EUR 7.5 MILLION FROM DEVELOPMENT AND COMMERCIAL MILESTONE PAYMENTS

* TO RECEIVE TIERED ROYALTIES BASED ON ANNUAL NET SALES OF PREOB IN JAPAN Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below